Literature DB >> 8375519

Ovulation after intravenous and intramuscular human chorionic gonadotropin.

R A Fischer1, S T Nakajima, M Gibson, J R Brumsted.   

Abstract

OBJECTIVE: To define the time interval from intravenous and intramuscular hCG administration to follicular wall rupture and the endocrinologic events associated with ovulation.
DESIGN: Subjects were studied in two cycles and received hCG either 10,000 IU IM or 500 IU IV in a random sequence with an intervening spontaneous menstrual cycle. PATIENTS: Thirty women from the University of Vermont Reproductive Endocrinology Service with unexplained, male, or cervical factor infertility.
INTERVENTIONS: Subjects underwent superovulation with clomiphene citrate followed by hCG administration when the lead follicle reached a mean diameter of 18 mm. Follicular rupture was determined by ultrasound monitoring every 2 hours starting 31 and 30 hours after intravenous and intramuscular hCG, respectively. Serum samples were obtained hourly for hormone measurements. The study was completed 2 hours after follicular rupture or 48 hours after hCG administration.
RESULTS: Twenty-five subjects received both intramuscular and intravenous hCG. The mean time to ovulation was 40.4 hours after intramuscular hCG (range, < or = 36 to > or = 48 hours) and 38.3 hours after intravenous hCG (range, 33 to > or = 48 hours). No differences were noted in the time interval to ovulation or rate of change in circulating E2 and P levels after IM versus IV hCG administration.
CONCLUSIONS: These findings suggest (1) ovulation occurs over a broad range of time after hCG administration; (2) ovulation does not occur in a more specific time interval after intravenous than intramuscular hCG; and (3) the rate of change in circulating E2 and P levels are not different after intravenous than intramuscular hCG.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375519

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Low plasma levels of hCG after 10,000-IU hCG injection do not reduce the number or maturation of oocytes recovered in patients undergoing assisted reproduction.

Authors:  S al-Hassan; S Fishel; S Fleming; S Thornton
Journal:  J Assist Reprod Genet       Date:  1998-11       Impact factor: 3.412

2.  The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis.

Authors:  Wei Wang; Xue-Hong Zhang; Wei-Hua Wang; Ya-Li Liu; Li-Hui Zhao; Shi-Long Xue; Ke-Hu Yang
Journal:  J Assist Reprod Genet       Date:  2011-07-27       Impact factor: 3.412

3.  Recombinant or urinary human chorionic gonadotropin in ovulation induction?

Authors:  Gautam Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2012-01-17

4.  Recombinant-human luteinizing hormone (r-hLH) as ovulatory stimulus in superovulated does.

Authors:  J A Peinado; I Molina; M Pla; J A Tresguerres; A Romeu
Journal:  J Assist Reprod Genet       Date:  1995-01       Impact factor: 3.412

5.  Two different timings of intrauterine insemination for non-male infertility.

Authors:  F J Huang; S Y Chang; Y J Lu; F T Kung; M Y Tsai; J F Wu
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

6.  Study of two strategies to induce follicular wave emergence for assisted reproductive treatments (ART)-a preliminary trial.

Authors:  Paulo H M Bianchi; Lais M Viera; Gabriela R F C A Gouveia; André M Rocha; Pietro S Baruselli; Edmund C Baracat; Paulo C Serafini
Journal:  J Assist Reprod Genet       Date:  2015-02-21       Impact factor: 3.412

7.  Serum human chorionic gonadotropin levels on the day before oocyte retrieval do not correlate with oocyte maturity.

Authors:  Gary Levy; Micah J Hill; Christina Ramirez; Torrie Plowden; Justin Pilgrim; Robin S Howard; James H Segars; John Csokmay
Journal:  Fertil Steril       Date:  2013-01-30       Impact factor: 7.329

8.  Ectopic pregnancy and failed oocyte retrieval during in vitro fertilization stimulation: Two case reports.

Authors:  Wen-Jie Zhou; Bu-Fang Xu; Zhi-Hong Niu
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.